Detection of Apoptotic Tumor Response In Vivo After a Single Dose of Chemotherapy with 99mTc-Annexin V
Takafumi Mochizuki, MD1,
Yuji Kuge, PhD2,
Songji Zhao, MD3,
Eriko Tsukamoto, MD3,
Masuo Hosokawa, MD4,
H. William Strauss, MD5,
Francis G. Blankenberg, MD6,
Jonathan F. Tait, PhD7 and
Nagara Tamaki, MD3
1 Department of Radiology, Nikko Memorial Hospital, Muroran, Japan
2 Department of Tracer Kinetics, Graduate School of Medicine, Hokkaido University, Sapporo, Japan
3 Department of Nuclear Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan
4 Department of Pathological Oncology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan
5 Department of Nuclear Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York
6 Division of Nuclear Medicine, Department of Radiology, Stanford University School of Medicine, Stanford, California
7 Department of Laboratory Medicine, University of Washington, Seattle, Washington

View larger version (17K):
[in a new window]
|
FIGURE 1. Uptake of 99mTc-annexin V (A) and number of TUNEL-positive cells (B) in tumor. Uptake of 99mTc-annexin V and number of TUNEL-positive cells were significantly higher in treated tumor than in control tumor. Control = control rats; treated = rats treated with cyclophosphamide (150 mg/kg intraperitoneally).
|
|

View larger version (149K):
[in a new window]
|
FIGURE 2. TUNEL staining (x200) of tumor specimens in control rats (A) and treated rats (B). Cells stained brown were considered TUNEL positive. TUNEL-positive cells were observed in tumor specimens obtained from both control and treated rats.
|
|
Copyright © 2003 by the Society of Nuclear Medicine.